Chemical Structure (Dapto 01)
Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 72572-100
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 72572-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (350 mg Vial Carton)
This is the product information of Daptomycin for Injection, which is administered intravenously after reconstituting with 0.9% Sodium Chloride Injection. Each single-dose vial contains 350mg of daptomycin and must be refrigerated (2°C - 8°C or 36°F - 46°F) before and after reconstitution. The product is manufactured in Hyderabad, Telangana, India, and distributed by Civica, Inc. The package insert provides information on dosage and administration. Parenteral drug products must be inspected for particulate matter before use.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
